C.M. Bidwell & Associates »

Neurocrine Biosciences shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2023-09-30 $100k 889 112.50
2022-12-31 $50k 419 119.44
2022-09-30 $45k 419 107.40
2018-09-30 $34k 275 123.64

More positions owned by C.M. Bidwell & Associates

iShares Russell 1000 Index (IWB)
iShares Russell 2000 Index (IWM)
Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Vanguard Short-Term Bond ETF (BSV)
Ishares Tr core strm usbd (ISTB)
Vanguard Europe Pacific ETF (VEA)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares MSCI ACWI ex US Index Fund (ACWX)
Schwab Strategic Tr 0 (SCHP)
Vanguard Total Bond Market ETF (BND)
Schwab U S Broad Market ETF (SCHB)
Schwab Strategic Tr us lrg cap etf (SCHX)
Dimensional Etf Trust (DFAC)

View all positions for C.M. Bidwell & Associates

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences